Breaking News, World News and Taiwan News.

Swine flu vaccine ready for clinical trials

While millions could catch the flu, governments and health experts around the world have sought to play down fears that influenza A(H1N1) could become a major killer.

Swine flu has so far infected almost 30,000 people in 74 countries and claimed 145 lives since it was first detected in Mexico in April, according to WHO figures.

Swiss drugs firm Novartis says it has completed a first batch of vaccine for pre-clinical trials and aims to make a version available in about four months.

"Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeks ahead of expectations," the company said in a statement.

The batch "will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials," it said.

Novartis hopes to start the trials in July and to gain a licence soon after. It said more than 30 governments had already asked for A(H1N1) virus "vaccine ingredients".

The UN health agency raised its global alert to a maximum six on Thursday after experts agreed that swine flu has reached pandemic status because of its geographical spread.

WHO Director General Margaret Chan said the declaration of a "moderate" pandemic should not spark panic and did not mean the A(H1N1) death toll would rise sharply.

She said raising the alert "means that the world is moving into the early days of its first influenza pandemic in the 21st century."

The WHO said it would ask drug-makers to quickly prepare to produce swine flu vaccines once the production of seasonal flu vaccine ends.

The Southern Hemisphere is currently heading toward winter and the height of its flu season. Northern Hemisphere countries expect to see a swine flu surge when its winter starts later.

Mexico has been worst hit. Its government on Thursday increased the country's death toll to 109 with 6,294 A(H1N1) infections. The United States comes next. Its health authorities have 27 deaths and 13,217 cases. Novartis received 289 million dollars from the US government for the development of the vaccine.

Australia, the worst hit in the Asia-Pacific region, was considering raising its national flu alert and adopting powers to cancel sports events, restrict travel and even shut national borders, although officials stressed extreme measures are unlikely.

Write a Comment
CAPTCHA Code Image
Type in image code
Change the code
 Receive China Post promos
 Respond to this email
 Swine flu vaccine ready for clinical trials 
In this file photo, a man passes the Logo of Swiss pharmaceutical company Novartis at the company's headquarters in Basel, Switzerland. Swiss pharmaceuticals company Novartis AG said Friday June 12, 2009 it has successfully produced a first batch of swine flu vaccine weeks ahead of expectations. The vaccine was made in cells, rather than grown in eggs as is usually the case with vaccines. (AP)

Enlarge Photo
Sponsors
Buy china wholesale products from reliable chinese wholesalers on DHgate.com!
Save 70% for hotel in Shanghai and 6000 hotels, in Beijing, Guangzhou, Shenzhen, and all China.
Get the best deals for Guangzhou Hotels or choose from more than 10,000 hotels in 499 Chinese cities.
Find great real time deals on China Flights. Book flights to China or China domestic flights 24/7.
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Listings  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   English Courses  |   Terms of Use  |   Sitemap
  chinapost search